RSS Feeds
Search

Press releases

Press releases

Displaying 1..10 of 71 - per page Next page
Order by
Genesis 2010, Westminster, Thursday 9 December is on track to attract a larger than ever attendance to debate new medicines and healthcare products research. More
A flavonoid derived from citrus fruit has shown tremendous promise for preventing weight gain and other signs of metabolic syndrome which can lead to Type 2 Diabetes and increased risk of cardiovascular disease. More
Cambridge, 4 November 2010 - One Nucleus, the not-for-profit membership company for international life science and healthcare companies, is to launch a series of high level conferences focused on specific technology areas, replacing its annual BioPartneri More
Diabetics may soon be able to wear contact lenses that continuously alert them to variations in their glucose levels by changing colours - replacing the need to routinely draw blood throughout the day. More
tesa AG, based in Hamburg, has acquired Labtec Gesellschaft für technologische Forschung und Entwicklung mbH More
New summary from Partneringdesk highlights trends in dealmaking from the top pharma and biotech companies More
A dozen University of Western Ontario research projects, including ensuring innovative research on Metabolic Syndrome and personalized medicine, have received $19-million from the Ontario Research Fund. More
Bridgehead International has been honoured with The Queen's Award for Enterprise 2007, in the International Trade section, for outstanding achievement in international trade More
New edition of report on opportunities in Indian pharma and biotech features partnering opportunities in companies, life science research institutes and biotech parks More
Pharmalicensing now offers in-depth and involved consulting to guide you through the process of licensing More
Displaying 1..10 of 71 - per page Next page
Order by

Related Reports

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us